|
Variable†
| |
Odds ratio
|
95% CI‡
|
|---|
|
Pretreatment HCV RNA level§
|
Per 1 log increase
|
0.179
|
0.096–0.336
|
|
HCV genotype
|
1b = 1; non-1b = 0
|
0.324
|
0.151–0.695
|
|
IFN-α regimen
|
6-MU = 1; 3-MU = 0¶
|
2.310
|
1.070–4.990
|
|
Stage of fibrosis
|
F3–4 = 1; F0–2 = 0
|
0.408
|
0.104–0.892
|
- † Factors included, age, sex, history of transfusion, pretreatment serum level of alanine aminotransferase and hepatitis C virus RNA, hepatitis C virus genotype, total necroinflammatory activity score, fibrosis score, interferon preparation, and interferon dose.
- ‡ CI: confidence interval.
- § HCV: hepatitis C virus.
- ¶ 3-MU group: interferon-α 3 million units thrice weekly for 24 weeks; 6-MU group: interferon-α 6 million units thrice weekly for 24 weeks.
